Evidence map›Paper›PMID 27420101›Full record

ArticlePathogens (Basel, Switzerland)2016

Bacterial Suppression of RNA Polymerase II-Dependent Host Gene Expression.

Ines Ambite, Nataliya Lutay, Christoph Stork, Ulrich Dobrindt, Björn Wullt, Catharina Svanborg

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Macrophages Infected by a Pathogen and a Non-pathogen Spotted Fever GroupFrontiers in cellular and infection microbiology · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ines AmbiteDepartment of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, 22184 Lund, Sweden. ines.ambite@med.lu.se.
Nataliya LutayDepartment of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, 22184 Lund, Sweden. nataliya.lutay@gmail.com.
Christoph StorkInstitute of Hygiene, University Hospital Münster, Westfälische Wilhelms-Universität, 48149 Münster, Germany. christoph.stork@ukmuenster.de.
Ulrich DobrindtInstitute of Hygiene, University Hospital Münster, Westfälische Wilhelms-Universität, 48149 Münster, Germany. dobrindt@uni-muenster.de.
Björn WulltDepartment of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, 22184 Lund, Sweden. bjorn.wullt@med.lu.se.
Catharina SvanborgDepartment of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, 22184 Lund, Sweden. catharina.svanborg@med.lu.se.
Lund University · SEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asymptomatic bacteriuria (ABU) is a bacterial carrier state in the urinary tract that resembles commensalism at other mucosal sites. ABU strains often lack the virulence factors that characterize uropathogenic Escherichia coli (E. coli) strains and therefore elicit weak innate immune responses in the urinary tract. In addition, ABU strains are active modifiers of the host environment, which they influence by suppressing RNA polymerase II (Pol II)-dependent host gene expression. In patients inoculated with the ABU strain E. coli 83972, gene expression was markedly reduced after 24 h (>60% of all regulated genes). Specific repressors and activators of Pol II-dependent transcription were modified, and Pol II Serine 2 phosphorylation was significantly inhibited, indicating reduced activity of the polymerase. This active inhibition included disease-associated innate immune response pathways, defined by TLR4, IRF-3 and IRF-7, suggesting that ABU strains persist in human hosts by active suppression of the antibacterial defense. In a search for the mechanism of inhibition, we compared the whole genome sequences of E. coli 83972 and the uropathogenic strain E. coli CFT073. In addition to the known loss of virulence genes, we observed that the ABU strain has acquired several phages and identified the lytic Prophage 3 as a candidate Pol II inhibitor. Intact phage particles were released by ABU during in vitro growth in human urine. To address if Prophage 3 affects Pol II activity, we constructed a Prophage 3 negative deletion mutant in E. coli 83972 and compared the effect on Pol II phosphorylation between the mutant and the E. coli 83972 wild type (WT) strains. No difference was detected, suggesting that the Pol II inhibitor is not encoded by the phage. The review summarizes the evidence that the ABU strain E. coli 83972 modifies host gene expression by inhibition of Pol II phosphorylation, and discusses the ability of ABU strains to actively create an environment that enhances their persistence.

Indexed as

asymptomatic bacteriuriagene expressionphagesRNA polymerase IItranscriptional modulation

Identifiers

PMID27420101
PMCPMC5039429
OpenAlexW2462276016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.